Prakt. lékáren. 2018; 14(4): 162-169 | DOI: 10.36290/lek.2018.031

Medicinal products and dietary supplements affecting unfavorable symptoms of climacterium

Jan Vosátka1, Barbora Vaňková1, Simona Dvořáčková1, Josef Malý1,2
1 Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové
2 Oddělení klinické farmacie, Nemocniční lékárna, Fakultní nemocnice v Motole, Praha

The climacteric period is accompanied by numerous symptoms that negatively affect women's quality of life and often lead tovisit to a health care professional. In a physician's office or in a pharmacy, it is important to choose an appropriate therapeuticstrategy based on an individual assessment of the pharmacotherapy risk and benefit. Nowadays, there is a wide spectrum ofdrugs that can be used for the climacteric symptoms. The aim of the article was to show the therapeutic options that influencethe climacteric symptoms including prescribed drugs and over-the-counter drugs. Furthermore, the article contains a review offood supplements and their possible use in climacterium.

Keywords: climacterium, menopause, hormonal replacement therapy, over‑the‑
counter drugs, dietary supplements

Published: December 15, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vosátka J, Vaňková B, Dvořáčková S, Malý J. Medicinal products and dietary supplements affecting unfavorable symptoms of climacterium. Praktické lékárenství. 2018;14(4):162-169. doi: 10.36290/lek.2018.031.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fait T. Klimakterická medicína. 2. ed. Praha: Maxdorf; 2013. 1-189. ISBN: 9788073453428.
    2. Ortmann O, Lattrich C. The treatment of climacteric symptoms. Dtsch Arztebl Int. 2012;109(17): 316-323; quiz 24. Go to original source... Go to PubMed...
    3. Malý J, Doseděl M. Volně prodejné přípravky používané v peri- a postmenopauze. Praktické lékarenství. 2012; 8(4): 181-186.
    4. Kubíková D. Menopauzální symptomy a hormonální substituční terapie. Praktické lékarenství. 2014; 10(2): 68-73.
    5. Živný J, Fait T. Endokrinologie klimakteria a hormonální substituční terapie. Psychiatrie pro praxi. 2003; 3: 101-106.
    6. de Azevedo Guimaraes AC, Baptista F. Influence of habitual physical activity on the symptoms of climacterium/menopause and the quality of life of middle-aged women. International journal of women's health. 2011; 3: 319-328. Go to original source... Go to PubMed...
    7. Rešlová T. Menopauza - léčba potíží. Medicína pro praxi. 2012; 9(11): 445-450.
    8. Blažková Š, Vytřísalová M, Vlček J. Osteoporóza: léčebně-preventivní opatření. Remedia. 2006; 16: 354-361.
    9. Horák P, Skácelová M. Současné možnosti léčby postmenopauzální osteoporózy. Klinická farmakologie a farmacie. 2014; 28(3): 99-104.
    10. Hanáček J. Klimakterium a hormonální terapie v gynekologické praxi. Postgraduální medicína. 2009.
    11. SÚKL. ATC, SPC 2018. Citováno 18. 10. 2018. Dostupné z: http://www.sukl.cz/modules/medication/atc_tree.php?current=H#H.
    12. Křepelka P. Menopauzální hormonální léčba - aktuální stav. Remedia. 2017; 5: 489-493.
    13. Bakour SH, Williamson J. Latest evidence on using hormone replacement therapy in the menopause. The Obstetrician & Gynaecologist, 2015; 17(1): 20-28. Go to original source...
    14. Bateson D, McNamee K. Perimenopausal contraception: A practice-based approach. Australian family physician. 2017; 46(6): 372-327. Go to PubMed...
    15. Koliba P. Výhody transdermálních forem HRT z pohledu gynekologa. Klinická farmakologie a farmacie. 2015; 29(2): 80-83.
    16. Vlček J, Vytřísalová M. et al. Klinická farmacie II. Praha: Grada; 2014. ISBN: 9788024745329.
    17. Meeta, Digumarti L, Agarwal N, Vaze N, Shah R, Malik S. Clinical practice guidelines on menopause: An executive summary and recommendations. Journal of mid-life health. 2013; 4(2): 77-106. Go to original source... Go to PubMed...
    18. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2015; 100(11): 3975-4011. Go to original source... Go to PubMed...
    19. Neves ECM, Birkhauser M, Samsioe G, Lambrinoudaki I, Palacios S, Borrego RS, et al. EMAS position statement: The ten point guide to the integral management of menopausal health. Maturitas. 2015; 81(1): 88-92. Go to original source... Go to PubMed...
    20. Živný J. Stárnutí ženy a hormonální substituční terapie. Interní medicína pro praxi. 2004; 8: 403-409.
    21. Kubíková D. Menopauzální symptomy a hormonální substituční terapie - Doporučený postup. Česká lékarnická komora. 2014: 1-8.
    22. Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V, et al. Short-term and long-term effects of tibolone in postmenopausal women. The Cochrane database of systematic reviews. 2016; 10: Cd008536. Go to original source... Go to PubMed...
    23. Archer DF, Hendrix S, Gallagher JC, Rymer J, Skouby S, Ferenczy A, et al. Endometrial effects of tibolone. The Journal of clinical endocrinology and metabolism. 2007; 92(3): 911-918. Go to original source... Go to PubMed...
    24. Micromedex. Drug Interactions 2018. Citováno 18. 10. 2018. Dostupné z: https://www.micromedexsolutions.com/micromedex2/librarian/CS/020F8A/ND_PR/evidencexpert/ND_P/evidencexpert/DUPLICATIONSHIELDSYNC/B6F7D3/ND_PG/evidencexpert/ND_B/evidencexpert/ND_AppProduct/evidencexpert/ND_T/evidencexpert/PFActionId/evidencexpert.FindDrugInteractions?navitem=topInteractions&isToolPage=true.
    25. AISLP. Mikro-verze AISLP - ČR. Verze 2018.3 pro MS Windows. 2018.
    26. Spilková J, Martin J, Siatka T et al. Farmakognozie. Praha: Karolinum; 2016. 348. ISBN: 9788024632643
    27. Kašparová M. Fytoestrogeny z jetele lučního. Praktické lékarenství. 2013; 9(4-5): 201-203.
    28. Eden JA. Phytoestrogens for menopausal symptoms: a review. Maturitas. 2012;7 2(2): 157-159. Go to original source... Go to PubMed...
    29. Lagari VS, Levis S. Phytoestrogens for menopausal bone loss and climacteric symptoms. The Journal of steroid biochemistry and molecular biology. 2014; 139 :294-301. Go to original source... Go to PubMed...
    30. Vrzáňová M, Heresová J. Fytoestrogeny. Interní medicína pro praktické lékaře. 2004; 1: 19-21.
    31. Togel B, Greve B, Raulin C. Current therapeutic strategies for hyperhidrosis: a review. European journal of dermatology. 2002; 12(3): 219-223.
    32. Mikušová K. Poradenství snižování nadváhy a léčba obezity - Doporučený postup. Česká lékarnická komora. 2010: 1-8.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.